A proportion of patients under surveillance for recurrent bladder carcinoma with no
immediate evidence of bladder tumor recurrence have positive multitarget fluorescence in …

What's known on the subject? and What does the study add? Radical nephroureterectomy
(RNU), the standard of care treatment for high‐risk urothelial carcinoma of the upper tract …

Bladder cancer is the fourth leading cause of cancer in American men, accounting for more
than 12,000 deaths annually. It was one of the first malignancies in which carcinogens were …

PURPOSE: Squamous cell carcinomas of the renal pelvis and ureter are rare. We report a
large series of patients and compare it to patients with urothelial carcinoma. MATERIALS …

A clinicopathologic study of 108 cases of high-grade urothelial carcinomas of the renal
pelvis is presented. Of the 108 tumors, 44 (40%) showed unusual morphologic features …

Abstract Purpose: The Polycomb group gene, EZH2, functions as a transcriptional repressor
involved in gene silencing. Amplification of EZH2 has been reported in several …

Molecular stratification of tumors by gene expression profiling has been applied to a large
number of human malignancies and holds great promise for personalized treatment …

Multifocal occurrence and frequent recurrence are characteristic features of urothelial
carcinomas of both the urinary bladder and the upper urinary tract. To describe the clonal …

Purpose: We compared blue light flexible cystoscopy with white light flexible cystoscopy for
the detection of bladder cancer during surveillance. Materials and Methods: Patients at high …

Abstract The 2022 International Society of Urological Pathology (ISUP) Consensus
Conference on Urinary Bladder Cancer Working Group 2 was tasked to provide evidence …